Share This Page
Explore the Possibilities
and Advance with Us.
Post Doctoral Associate - 31795
Job Number: 2018-31795
Category: Post Doc
Location: Worcester, MA
Shift: Day
Exempt/Non-Exempt: Exempt
Business Unit: UMass Chan Medical School
Department: School - Molecular Cell & Cancer Biology - W495000
Job Type: Full-Time
Salary Grade: 86
Union Code: Non Union Position-W63-Residents/Post Docs
Num. Openings: 1
Post Date: April 15, 2019

The Wolfe laboratory will be filling a postdoctoral position to develop new delivery reagents/methods for Cas9-based nucleases for somatic cell genome editing in collaboration with the Khvorova, Sontheimer and Watts labs at UMMS. This project is associated with the NIH Common Fund Somatic Cell Genome Editing program (https://commonfund.nih.gov/editing)

Our experimental efforts will focus on:

1) The development of new guide RNA compositions to facilitate delivery of Cas9 and Cpf1 to somatic cells.

2) The development of new nuclease platforms with improved delivery and precision properties.

Candidates should have a Ph.D. in biology, biochemistry, chemistry or a related biomedical science. In addition, the potential candidate must have strong oral and written communication skills and be eager to present research results at national meetings. Prior experience with CRISPR-Cas9 nuclease platforms, cell culture, and deep-sequencing technologies is advantageous, but not required.

TO APPLY:

Applicants should send a letter (via email) describing their current research activities and their interest in this position, a CV (including publications) and contact information for three references, including your Ph.D. advisor.

Address letters to Scot Wolfe at: scot.wolfe@umassmed.edu

Further details about the Wolfe laboratory and the positions that are available can be found at https://www.umassmed.edu/Wolfe-Lab/

https://profiles.umassmed.edu/display/133161

Check Out Our Advancing Careers 
HR Blog

UMass Chan Medical School was among 23 companies that stood out as 2023 “DEI champions,” according to The Boston Globe.   


Named a U.S. News & World Report
“2023 BEST MEDICAL GRAD SCHOOL”
for Primary Care and Research